Retension Pharmaceuticals, Inc. - Common Stock (NQ:RTSN)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
20.6% below 52-week high
14.79
9.6652W Low
18.6452W High
1 Week
20.6% below 1-week high
11.561W Low
18.641W High
Retension Pharmaceuticals, Inc. - Common Stock (RTSN) traded between $9.66 and $18.64 over the past 52 weeks and last traded at $14.79, 20.6% below its 52-week high. Over the past week it ranged between $11.56 and $18.64.
Past 12 Months
1W
+$2.58
1M
+$4.27
3M
+$4.27
6M
+$4.27
YTD
+$4.27
1Y
+$4.27
RTSN was +40.5% over the past year, +40.5% over six months, +40.5% year to date, +21.2% in the last week.
12 Months vs Market
RTSN
DIA
SPY
QQQ
IWM
Over the past 12 months RTSN returned +40.5% versus DIA (Dow) +12.3%, SPY (S&P 500) +13.7%, QQQ (Nasdaq 100) +15.5% and IWM (Russell 2000) +11.7%.
Volume & Liquidity
0.34× 3-mo avg
Today 75,594
3-mo avg 221.6K
1W
1M
3M
6M
YTD
1Y
RTSN most recently traded 75,594 shares against a 3-month average daily volume of 221.6K. Frequently Asked QuestionsIs Retension Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Retension Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Retension Pharmaceuticals, Inc. - Common Stock trade on?
Retension Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Retension Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Retension Pharmaceuticals, Inc. - Common Stock is RTSN on the Nasdaq Stock Market
What is the current price of Retension Pharmaceuticals, Inc. - Common Stock?
The current price of Retension Pharmaceuticals, Inc. - Common Stock is 14.79
When was Retension Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Retension Pharmaceuticals, Inc. - Common Stock was at 10/22/26 01:40 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
|